Medical Properties Trust, Inc. (NYSE:MPW) insider Emmett E. Mclean sold 50,000 shares of the company’s stock in a transaction that occurred on Tuesday, December 4th. The stock was sold at an average price of $17.40, for a total value of $870,000.00. Following the completion of the sale, the insider now directly owns 913,965 shares of the company’s stock, valued at approximately $15,902,991. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.
MPW traded down $0.39 during midday trading on Friday, hitting $17.10. The stock had a trading volume of 220,568 shares, compared to its average volume of 2,744,423. The firm has a market cap of $6.30 billion, a P/E ratio of 12.69, a P/E/G ratio of 3.21 and a beta of 0.50. The company has a debt-to-equity ratio of 0.90, a current ratio of 4.92 and a quick ratio of 4.92. Medical Properties Trust, Inc. has a 1 year low of $11.82 and a 1 year high of $17.52.
Medical Properties Trust (NYSE:MPW) last issued its earnings results on Thursday, November 1st. The real estate investment trust reported $0.35 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.34 by $0.01. The business had revenue of $197.00 million during the quarter, compared to analyst estimates of $192.64 million. Medical Properties Trust had a return on equity of 9.06% and a net margin of 124.88%. Medical Properties Trust’s revenue for the quarter was up 11.6% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.33 earnings per share. On average, equities analysts anticipate that Medical Properties Trust, Inc. will post 1.37 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, January 10th. Stockholders of record on Thursday, December 13th will be paid a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a dividend yield of 5.85%. The ex-dividend date of this dividend is Wednesday, December 12th. Medical Properties Trust’s dividend payout ratio (DPR) is presently 74.07%.
MPW has been the subject of several research reports. JMP Securities set a $16.00 target price on Medical Properties Trust and gave the stock a “buy” rating in a research note on Monday, October 1st. ValuEngine raised Medical Properties Trust from a “hold” rating to a “buy” rating in a research note on Saturday, November 10th. Stifel Nicolaus set a $14.00 target price on Medical Properties Trust and gave the stock a “hold” rating in a research note on Thursday, November 1st. Zacks Investment Research raised Medical Properties Trust from a “sell” rating to a “hold” rating in a research note on Wednesday, November 7th. Finally, Mitsubishi UFJ Financial Group upped their target price on Medical Properties Trust to $15.00 and gave the stock a “neutral” rating in a research note on Friday, November 2nd. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating and two have assigned a buy rating to the company. Medical Properties Trust currently has an average rating of “Hold” and an average price target of $14.19.
Several large investors have recently added to or reduced their stakes in the company. Vanguard Group Inc. boosted its stake in shares of Medical Properties Trust by 0.9% during the third quarter. Vanguard Group Inc. now owns 52,939,728 shares of the real estate investment trust’s stock valued at $789,331,000 after purchasing an additional 454,630 shares during the period. BlackRock Inc. boosted its stake in shares of Medical Properties Trust by 2.1% during the third quarter. BlackRock Inc. now owns 41,840,443 shares of the real estate investment trust’s stock valued at $623,840,000 after purchasing an additional 846,940 shares during the period. Massachusetts Financial Services Co. MA boosted its stake in shares of Medical Properties Trust by 2.1% during the third quarter. Massachusetts Financial Services Co. MA now owns 21,516,682 shares of the real estate investment trust’s stock valued at $320,814,000 after purchasing an additional 448,361 shares during the period. LSV Asset Management boosted its stake in shares of Medical Properties Trust by 13.9% during the second quarter. LSV Asset Management now owns 10,487,800 shares of the real estate investment trust’s stock valued at $147,248,000 after purchasing an additional 1,280,000 shares during the period. Finally, Bank of New York Mellon Corp boosted its stake in shares of Medical Properties Trust by 3.2% during the third quarter. Bank of New York Mellon Corp now owns 9,384,794 shares of the real estate investment trust’s stock valued at $139,929,000 after purchasing an additional 288,334 shares during the period. 76.59% of the stock is owned by hedge funds and other institutional investors.
WARNING: This piece of content was originally published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this piece of content on another publication, it was illegally stolen and republished in violation of US & international trademark & copyright legislation. The original version of this piece of content can be viewed at https://www.dispatchtribunal.com/2018/12/07/emmett-e-mclean-sells-50000-shares-of-medical-properties-trust-inc-mpw-stock.html.
Medical Properties Trust Company Profile
Medical Properties Trust, Inc is a self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. MPT's financing model helps facilitate acquisitions and recapitalizations and allows operators of hospitals and other healthcare facilities to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.
Featured Story: Why investors pay attention to retained earnings
Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.